Provider Consolidation: Implications for Costs and Quality in Health Care Delivery image

November 9, 2018 12:30 PM
Lectures and Panels
Room TBD
Harvard Medical School, Boston, MA

This event is free and open to all members of the Harvard community. Attendees will be required to show their Harvard ID in order to enter the venue.

Registration will be available here soon. Want updates sent straight to your inbox? Sign up for our newsletter!

The Health Policy and Bioethics Consortia is a monthly series that convenes two international experts from different fields or vantage points to discuss how biomedical innovation and health care delivery are affected by various ethical norms, laws, and regulations. 

They are organized by the Harvard Medical School Center for Bioethics and the Program on Regulation, Therapeutics, and Law (PORTAL) at Brigham and Women's Hospital, in collaboration with the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School. Support provided by the Oswald DeN. Cammann Fund at Harvard University.


bioethics   doctor-patient relationship   health care costs   health law policy   market   medical safety   regulation